2026 data Public-data reference. official source

Glucose Dehydrogenase, Glucose

Open-data reference.

FDA MAUDE adverse event data · 1998–2026

What the Data Shows About Glucose Dehydrogenase, Glucose

The FDA MAUDE database aggregates 73,910 adverse-event reports for Glucose Dehydrogenase, Glucose spanning the period from 1998 through 2026. Of these, 33 are classified as death reports, 5,130 as injury reports, and 68,691 as malfunction reports under FDA adverse-event categorization rules. Report counts do not by themselves indicate a device is unsafe — widely used devices and longer market histories naturally generate larger raw counts, so proportional and comparative reads are more informative than totals alone.

The adverse-event profile breaks down across 5 distinct event types and 14 reported patient-outcome categories, giving a multi-dimensional view that goes beyond a single headline number. A total of 20 distinct product-problem codes appear in the reports, with Incorrect Or Inadequate Test Results topping the list at 1,826 reports. Reports are associated with 10 different manufacturers in the MAUDE record, reflecting both OEMs and repackagers of this device category.

Annual reporting volume is tracked across 29 years of MAUDE data, with the peak single-year volume reaching 23,813 reports — trend shape often reflects changes in device adoption, reporting rules, or FDA enforcement focus rather than underlying device behavior alone. Events are documented across 35 reported care-setting categories (hospital, home, ambulatory surgery center, etc.). All figures reflect the openFDA MAUDE snapshot last refreshed on . This page is informational and is not medical advice — discuss device-safety questions with your healthcare provider.

73,910
Total Reports
33
Death Reports
5,130
Injury Reports
68,691
Malfunctions

Event Types

Malfunction 68,691 (92.9%)
Injury 5,130 (6.9%)
Death 33 (0.0%)
Other 32 (0.0%)
24 (0.0%)

Patient Outcomes

68,567 (90.8%)
Required Intervention 2,763 (3.7%)
Hospitalization 1,639 (2.2%)
R 1,407 (1.9%)
Other 620 (0.8%)
Life Threatening 265 (0.4%)
L 164 (0.2%)
O 38 (0.1%)
Death 38 (0.1%)
H 27 (0.0%)
Congenital Anomaly 12 (0.0%)
Disability 10 (0.0%)
S 3 (0.0%)
D 1 (0.0%)

Top Product Problems

Incorrect Or Inadequate Test Results 1,826
High Test Results 644
Erratic Results 569
Incorrect, Inadequate or Imprecise Result or Readings 533
Low Test Results 257
Non Reproducible Results 244
Insufficient Information 174
Failure to Power Up 46
Device Displays Incorrect Message 10
Material Twisted/Bent 9
Labelling, Instructions for Use or Training Problem 8
High Readings 7
Incorrect Measurement 7
Low Readings 7
Patient Data Problem 7
Device Sensing Problem 6
Adverse Event Without Identified Device or Use Problem 5
Component Missing 5
Defective Device 5
Nonstandard Device 5

Yearly Trend

98
1998: 8
99
1999: 13
00
2000: 20
01
2001: 119
02
2002: 260
03
2003: 296
04
2004: 835
05
2005: 1,118
06
2006: 2,767
07
2007: 23,813
08
2008: 6,583
09
2009: 10,822
10
2010: 4,865
11
2011: 3,802
12
2012: 3,341
13
2013: 3,821
14
2014: 3,960
15
2015: 3,366
16
2016: 2,145
17
2017: 103
18
2018: 108
19
2019: 108
20
2020: 132
21
2021: 164
22
2022: 101
23
2023: 103
24
2024: 171
25
2025: 836
26
2026: 130

Related Entities for Glucose Dehydrogenase, Glucose

Event Locations

31,800 (43.0%)
OTHER 14,470 (19.6%)
U 12,107 (16.4%)
HOME 6,689 (9.1%)
HOSPITAL 2,832 (3.8%)
I 2,506 (3.4%)
UNKNOWN 1,907 (2.6%)
NOT APPLICABLE 1,040 (1.4%)
NO INFORMATION 104 (0.1%)
SCHOOL 87 (0.1%)
AMBULATORY HEALTH CARE FACILITY 80 (0.1%)
PATIENT'S HOME 72 (0.1%)
CLINIC - WALK IN, OTHER 48 (0.1%)
NURSING HOME 42 (0.1%)
LABORATORY 38 (0.1%)
LONG-TERM CARE FACILITY 21 (0.0%)
REHABILITATION CENTER 15 (0.0%)
EMERGENCY ROOM 9 (0.0%)
OUTPATIENT TREATMENT FACILITY 5 (0.0%)
RETIREMENT HOME 5 (0.0%)
OUTDOORS 4 (0.0%)
PSYCHIATRIC FACILITY 4 (0.0%)
PUBLIC BUILDING 4 (0.0%)
AMBULATORY SURGICAL CENTER 3 (0.0%)
CRITICAL CARE UNIT 3 (0.0%)
AMBULATORY SURGICAL FACILITY 2 (0.0%)
EXAMINATION ROOM 2 (0.0%)
INVALID DATA 2 (0.0%)
PARK 2 (0.0%)
STREET 2 (0.0%)
DIALYSIS CENTER 1 (0.0%)
DIALYSIS UNIT 1 (0.0%)
IN TRANSIT TO USER/MEDICAL FACILITY 1 (0.0%)
PUBLIC VENUE 1 (0.0%)
URGENT CARE CENTER 1 (0.0%)

Compare ROCHE DIAGNOSTICS vs ABBOTT DIABETES CARE INC, USA →

Data Source

FDA Manufacturer and User Facility Device Experience (MAUDE) database via the openFDA API. Reports are submitted by manufacturers, healthcare facilities, and patients. Report counts do not indicate a device is unsafe — higher-use devices naturally generate more reports.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the FDA MAUDE database. Consult a qualified professional before making decisions based on this data.